| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $30,708,002 ) (Continued on the next page) |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AG076812 | Providers and Older Pain Patients with Prescription Opioid Dependence: A Qualitative Study to Understand Barriers to Opioid Taper, Cessation, and Transition to Buprenorphine. | 000 | 1 | NIH | 9/18/2023 | $416,625 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE152492 | Community Project Funding/Congressionally Directed Spending - Construction | 00 | 1 | HRSA | 9/19/2023 | $4,000,000 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30HL170694 | The Role of Plasmalogen Mitochondrial and Endothelial Antioxidant Properties in Sepsis | 000 | 1 | NIH | 8/15/2023 | $52,694 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM145783 | Structural dynamics of sphingosine-1-phosphate transporters as key therapeutic targets for immune system modulation and cancer | 000 | 1 | NIH | 9/18/2023 | $408,091 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA271033 | Actions for Collaborative Community Engaged Strategies for HPV (ACCESS HPV) | 001 | 2 | NIH | 8/18/2023 | $517,441 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56AG082759 | Role of cytosolic DNA-induced sterile inflammation driving cellular and organismal progeria/aging hallmarks | 000 | 1 | NIH | 9/19/2023 | $378,750 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01ES035365 | Lipid and metabolic mechanisms responsible for phosgene and phosphorus trichloride exposure toxicity | 000 | 1 | NIH | 8/15/2023 | $303,000 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK132162 | Determining hepatocyte-specific mechanisms by which Ube4A regulates NAFLD/NASH | 000 | 1 | NIH | 3/2/2023 | $514,249 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI150610 | Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | 000 | 3 | NIH | 11/2/2022 | $637,836 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL150146 | Structural Studies of Beta-2 glycoprotein I in the Antiphospholipid Syndrome | 000 | 4 | NIH | 1/9/2023 | $349,774 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS119263 | Anti-CV2 autoantibodies unmask a CRMP5/GluN2B pain signaling hub | 003 | 4 | NIH | 5/18/2023 | $377,686 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | D1930852 | Nursing Workforce Diversity | 00 | 7 | HRSA | 5/24/2023 | $549,111 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM133967 | Mechanisms of RPA, Recombinases, and Mediators in Homologous Recombination | 000 | 4 | NIH | 5/24/2023 | $9,848 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 002 | 7 | NIH | 2/28/2023 | $483,667 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM111835 | Automation of the chemical synthesis of human milk oligosaccharides | 001 | 9 | NIH | 11/23/2022 | $264,432 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS119263 | Anti-CV2 autoantibodies unmask a CRMP5/GluN2B pain signaling hub | 003 | 4 | NIH | 5/18/2023 | -$377,686 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS111120 | Novel therapeutic approaches for traumatic brain injury induced cognitive deficits | 000 | 4 | NIH | 12/1/2022 | $298,266 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | E0127037 | Nurse Faculty Loan Program | 00 | 4 | HRSA | 6/29/2023 | $194,316 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA238705 | Defining how obesity shapes immunity and the success of cancer immunotherapy | 000 | 5 | NIH | 7/20/2023 | $339,625 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AG064069 | Antisense Oligonucleotides for Targeting Nonsense-mediated mRNA Decay in Frontotemporal Dementia | 000 | 5 | NIH | 5/9/2023 | $378,750 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM111835 | Automation of the chemical synthesis of human milk oligosaccharides | 002 | 9 | NIH | 2/14/2023 | $29,380 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS111120 | Novel therapeutic approaches for traumatic brain injury induced cognitive deficits | 001 | 4 | NIH | 2/1/2023 | $33,140 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 02 | 8 | HRSA | 9/1/2023 | $5,678 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 01 | 8 | HRSA | 7/10/2023 | $114,733 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 01 | 8 | HRSA | 7/10/2023 | $1,600 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 00 | 8 | HRSA | 4/21/2023 | $100,000 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | U1Q28716 | Geriatrics Workforce Enhancement Program | 00 | 8 | HRSA | 4/21/2023 | $650,000 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK095112 | Regulatory Role of Transferrin in Erythropoiesis and Iron Metabolism | 000 | 6 | NIH | 5/8/2023 | $708,121 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS119263 | Anti-CV2 autoantibodies unmask a CRMP5/GluN2B pain signaling hub | 002 | 4 | NIH | 5/10/2023 | $377,686 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 009 | 4 | NIH | 8/8/2023 | $277,283 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL147821 | Structural enzymology of factor V activation | 000 | 5 | NIH | 5/1/2023 | $474,780 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DA043811 | Pathways from Chronic Prescription Opioid Use to New Onset Mood Disorder | 000 | 5 | NIH | 1/24/2023 | $547,792 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS119263 | Anti-CV2 autoantibodies unmask a CRMP5/GluN2B pain signaling hub | 000 | 4 | NIH | 12/21/2022 | $316,669 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U01DK061718 | The Saint Louis University Component of the NASH CRN | 000 | 22 | NIH | 8/18/2023 | $581,470 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R03AI178368 | Transcriptomic Quantitation of Hepatitis B Virus Surface Antigen from Integration | 000 | 1 | NIH | 5/11/2023 | $75,750 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK134531 | The Role of Inflammation in Regulating Gastric Metaplasia | 000 | 1 | NIH | 2/24/2023 | $572,370 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 002 | 1 | NIH | 2/17/2023 | $942 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R37CA265877 | Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer | 001 | 2 | NIH | 9/15/2023 | $30,000 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U01CA279863 | Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH) | 000 | 1 | NIH | 8/23/2023 | $593,289 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 000 | 1 | NIH | 12/15/2022 | $51,752 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R37CA265877 | Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer | 000 | 2 | NIH | 7/3/2023 | $398,511 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UG1HD113156 | Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST) | 000 | 1 | NIH | 9/6/2023 | $50,000 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30DK134124 | Defining Inflammatory Triggers that Induce Diverse Subtypes of Gastric Metaplasia | 001 | 1 | NIH | 12/15/2022 | $0 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS128004 | Uncovering the roles of oxysterols in neuropathic pain | 000 | 2 | NIH | 5/19/2023 | $582,767 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UG1HD113156 | Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST) | 000 | 1 | NIH | 9/6/2023 | $66,667 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA261979 | Fingolimod and Ozanimod for the treatment and prevention of chemobrain | 000 | 2 | NIH | 7/17/2023 | $461,866 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA263428 | Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer | 000 | 2 | NIH | 1/30/2023 | $211,736 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UG1HD113156 | Sustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST) | 000 | 1 | NIH | 9/6/2023 | $1,106,471 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R25AI170379 | NIAID STAR: Stimulating Training and Access to Research Experiences for Minority and Underrepresented Populations | 000 | 2 | NIH | 7/24/2023 | $345,423 |
|
